83 related articles for article (PubMed ID: 24937583)
1. An open-label clinical trial of milnacipran in fibromyalgia syndrome with co-morbid depressive symptoms.
Nagaoka S; Ohno M; Sekiguchi A
Int J Psychiatry Clin Pract; 2004; 8(1):47-51. PubMed ID: 24937583
[TBL] [Abstract][Full Text] [Related]
2. Relationships among pain, depressed mood, and global status in fibromyalgia patients: post hoc analyses of a randomized, placebo-controlled trial of milnacipran.
Arnold LM; Palmer RH; Gendreau RM; Chen W
Psychosomatics; 2012; 53(4):371-9. PubMed ID: 22677218
[TBL] [Abstract][Full Text] [Related]
3. Dual reuptake inhibitor milnacipran and spinal pain pathways in fibromyalgia patients: a randomized, double-blind, placebo-controlled trial.
Matthey A; Cedraschi C; Piguet V; Besson M; Chabert J; Daali Y; Courvoisier D; Montagne A; Dayer P; Desmeules JA
Pain Physician; 2013; 16(5):E553-62. PubMed ID: 24077206
[TBL] [Abstract][Full Text] [Related]
4. A double-blind placebo-controlled trial of milnacipran in the treatment of fibromyalgia.
Vitton O; Gendreau M; Gendreau J; Kranzler J; Rao SG
Hum Psychopharmacol; 2004 Oct; 19 Suppl 1():S27-35. PubMed ID: 15378666
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of milnacipran in the treatment of generalized anxiety disorder: an open study.
Tsukamoto T; Kondoh R; Ichikawa K
Int J Psychiatry Clin Pract; 2004; 8(4):255-8. PubMed ID: 24930555
[TBL] [Abstract][Full Text] [Related]
6. Milnacipran: serotonin-noradrenaline reuptake inhibitor approved for fibromyalgia may be a useful antidepressant.
Keks NA; Hope J; Keogh S; Copolov DL
Australas Psychiatry; 2018 Oct; 26(5):537-540. PubMed ID: 30198305
[TBL] [Abstract][Full Text] [Related]
7. A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder.
Arnold LM; Lu Y; Crofford LJ; Wohlreich M; Detke MJ; Iyengar S; Goldstein DJ
Arthritis Rheum; 2004 Sep; 50(9):2974-84. PubMed ID: 15457467
[TBL] [Abstract][Full Text] [Related]
8. A pooled analysis of two randomized, double-blind, placebo-controlled trials of milnacipran monotherapy in the treatment of fibromyalgia.
Geisser ME; Palmer RH; Gendreau RM; Wang Y; Clauw DJ
Pain Pract; 2011; 11(2):120-31. PubMed ID: 20642487
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of milnacipran in the treatment of chronic pain syndromes.
Kamata M; Naito S; Higuchi H; Suzuki A; Otani K
Int J Psychiatry Clin Pract; 2010 Mar; 14(1):68-71. PubMed ID: 24917235
[TBL] [Abstract][Full Text] [Related]
10. Milnacipran for the management of fibromyalgia syndrome.
Ormseth MJ; Eyler AE; Hammonds CL; Boomershine CS
J Pain Res; 2010 Mar; 3():15-24. PubMed ID: 21197306
[TBL] [Abstract][Full Text] [Related]
11. Durability of therapeutic response to milnacipran treatment for fibromyalgia. Results of a randomized, double-blind, monotherapy 6-month extension study.
Goldenberg DL; Clauw DJ; Palmer RH; Mease P; Chen W; Gendreau RM
Pain Med; 2010 Feb; 11(2):180-94. PubMed ID: 20002596
[TBL] [Abstract][Full Text] [Related]
12. A 3-year, open-label, flexible-dosing study of milnacipran for the treatment of fibromyalgia.
Arnold LM; Palmer RH; Ma Y
Clin J Pain; 2013 Dec; 29(12):1021-8. PubMed ID: 23446068
[TBL] [Abstract][Full Text] [Related]
13. Milnacipran: in fibromyalgia.
Chwieduk CM; McCormack PL
Drugs; 2010; 70(1):99-108. PubMed ID: 20030428
[TBL] [Abstract][Full Text] [Related]
14. Serotonin noradrenaline reuptake inhibitors: New hope for the treatment of chronic pain.
Delgado PL
Int J Psychiatry Clin Pract; 2006; 10 Suppl 2():16-21. PubMed ID: 24921678
[TBL] [Abstract][Full Text] [Related]
15. Milnacipran and pindolol: a randomized trial of reduction of antidepressant latency.
Isaac MT; Isaac MB; Gallo F; Tournoux A
Hum Psychopharmacol; 2003 Dec; 18(8):595-601. PubMed ID: 14696018
[TBL] [Abstract][Full Text] [Related]
16. Milnacipran: a selective serotonin and norepinephrine dual reuptake inhibitor for the management of fibromyalgia.
Palmer RH; Periclou A; Banerjee P
Ther Adv Musculoskelet Dis; 2010 Aug; 2(4):201-20. PubMed ID: 22870448
[TBL] [Abstract][Full Text] [Related]
17. Milnacipran for treatment of fibromyalgia.
Kyle JA; Dugan BD; Testerman KK
Ann Pharmacother; 2010 Sep; 44(9):1422-9. PubMed ID: 20716692
[TBL] [Abstract][Full Text] [Related]
18. Milnacipran hydrochloride: its efficacy, safety and tolerability profile in fibromyalgia syndrome.
Owen RT
Drugs Today (Barc); 2008 Sep; 44(9):653-60. PubMed ID: 19137120
[TBL] [Abstract][Full Text] [Related]
19. Early fluoxetine treatment of post-stroke depression--a three-month double-blind placebo-controlled study with an open-label long-term follow up.
Fruehwald S; Gatterbauer E; Rehak P; Baumhackl U
J Neurol; 2003 Mar; 250(3):347-51. PubMed ID: 12638027
[TBL] [Abstract][Full Text] [Related]
20. The psychiatrist confronted with a fibromyalgia patient.
Kasper S
Hum Psychopharmacol; 2009 Jun; 24 Suppl 1():S25-30. PubMed ID: 19479904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
